Douglas Losordo, M.D., FACC, FAHA, Senior Vice President of Clinical Medical and Regulatory Affairs and Chief Medical Officer to present.
- Session: Advances in Adult Stem Cell Research
- Title: Recent Breakthroughs with CD34+ Cell Therapy in Cardiovascular Disease: Insights from Clinical Trials in >700 Patients
- Date and Time: Thursday, April 12, 2018 at 10:55am EST
- Location: Hyatt Regency Boston Hotel, Boston, MA
In addition, Dr. Losordo will act as moderator for panels entitled “Regulatory Challenges in Cell Therapy” and “Revolution in Immunotherapy.”